University of Florida

Title	Investigator	Start	End
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET)	Tebb	10/24/12	10/25/18
DAA-SALVAGE: A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/ Pibrentasvir +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C previously treated with an NS5A Inhibitor + Sofosbuvir Therapy	Terrault	9/1/17	8/31/21

Title	Investigator	Start	End
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network-A Longitudinal, Observational Study	Khalili	8/1/08	9/30/10
Subcontract from UFL Prime: HIV/FIV-Cat-Model: A model to identify vaccine epitopes	Levy	7/1/06	6/30/11
nPOD Coordinating Center	Anderson	7/1/14	12/31/14
International Clinics on Infectious Disease Dynamics and Data (ICI3D Program)	Porco	3/1/14	5/31/15
RAPID: Understanding and leveraging asymptomatic infections to control Ebola transmission	Porco	11/1/15	12/31/16
Continuing Education for the Curry Center	Chen	1/1/13	12/31/17

Global Research Projects